Nebulized salbutamol is primarily used to manage hyperkalemia, a condition characterized by elevated serum potassium levels.
Its mechanism involves the activation of beta-2 adrenergic receptors, which stimulates the sodium-potassium ATPase (Na+/K+-ATPase) pump located on cell membranes. This stimulation enhances the movement of potassium ions (K+) from the extracellular fluid into the intracellular fluid.
This acute reduction in serum K+ makes salbutamol a valuable tool in the emergency management of hyperkalemia.